NLRP3 and B-cell chronic lymphocytic leukemia: However, modulation of NLRP3 expression by silencing in CLL lymphocytes is impractical as these cells cannot be easily transfected, thus we took advantage of two human leukemic cell lines, THP-1 and Ramos cells, that can be transfected and have a fast in vitro growth rate.